Active cocaine use is associated with lack of HIV-1 virologic suppression independent of nonadherence to antiretroviral therapy: Use of a rapid screening tool during routine clinic visits

References

• Arnsten , J.H. , Demas , P.A. , Grant , R.W. , Gourevitch , M.N. , Farzadegan , H. , Howard , A.A. and Schoenbaum , E.E. 2002 . Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users . Journal of General Internal Medicine , 17 ( 5 ) : 377 – 381 .
   PubMed Web of Science ®Google Scholar
• Bagasra , O. and Pomerantz , R.J. 1993 . Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine . Journal of Infectious Diseases , 168 ( 5 ) : 1157 – 1164 . doi: 10.1093/infdis/168.5.1157
   PubMed Web of Science ®Google Scholar
• Baum , M.K. , Rafie , C. , Lai , S. , Sales , S. , Page , B. and Campa , A. 2009 . Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users . Journal of Acquired Immune Deficiency Syndromes , 50 : 93 – 99 . doi: 10.1097/QAI.0b013e3181900129
   PubMed Web of Science ®Google Scholar
• Berg , K.M. , Wilson , I.B. , Li , X. , & Arnsten , J.H. 2012 . Comparison of antiretroviral adherence questions . AIDS and Behavior , 16 ( 2 ), 461 – 468 .
   PubMed Web of Science ®Google Scholar
• Bogart , L.M. , Kelly , J.A. , Catz , S.L. and Sosman , J.M. 2000 . Impact of medical and nonmedical factors on physician decision making for HIV/AIDS antiretroviral treatment . Journal of Acquired Immune Deficiency Syndromes , 23 ( 5 ) : 396 – 404 .
   PubMed Web of Science ®Google Scholar
• Bouhnik , A.D. , Preau , M. , Schiltz , M.A. , Peretti-Watel , P. , Obadia , Y. , Lert , F. , VESPA Group . 2006 . Unsafe sex with casual partners and quality of life among HIV-infected gay men: Evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA) . Journal of Acquired Immune Deficiency Syndromes 42 ( 5 ), 597 – 603 . doi: 10.1097/01.qai.0000221674.76327.d7
   PubMed Web of Science ®Google Scholar
• Cabral , G.A. 2006 . Drugs of abuse, immune modulation, and AIDS . Journal of Neuroimmune Pharmacology , 1 : 280 – 295 . doi: 10.1007/s11481-006-9023-5
   PubMed Web of Science ®Google Scholar
• CDC . 2008 . HIV Prevalence Estimates-United States, 2006 . MMWR 57 ( 39 ), 1073 – 1076 .
   PubMedGoogle Scholar
• Chesney , M.A. , Ickovics , J.R. , Chambers , D.B. , Gifford , A.L. , Neidig , J. , Zwickl , B. and Wu , A.W. 2000 . Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments . AIDS Care , 12 ( 3 ) : 255 – 266 . doi: 10.1080/09540120050042891
   PubMed Web of Science ®Google Scholar
• Cofrancesco , J. Jr , Scherzer , R. , Tien , P.C. , Gilbert , C.L. , Southwell , H. , Sidney , S. , Grunfeld , C. 2008 . Illicit drug use and HIV treatment outcomes in a US cohort . AIDS 22 ( 3 ), 357 – 365 . doi: 10.1097/QAD.0b013e3282f3cc21
   PubMed Web of Science ®Google Scholar
• Cook , J.A. , Burke-Miller , J.K. , Cohen , M.H. , Cook , R.L. , Vlahov , D. , Wilson , T.E. and Grey , D.D. 2008 . Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women . AIDS , 22 : 1355 – 1363 . doi: 10.1097/QAD.0b013e32830507f2
   PubMed Web of Science ®Google Scholar
• Deschamps , A.E. , De Geest , S. , Vandamme , A. , Bobbaers , H. , Peetermans , W.E. and Van Wijngaerden , E. 2008 . Diagnostic value of different adherence measures using electronic monitoring and virologic failure as reference standards . AIDS Patient Care and STDs , 22 ( 9 ) : 735 – 743 . doi: 10.1089/apc.2007.0229
   PubMed Web of Science ®Google Scholar
• Di Franco , M.J. , Sheppard , H.W. , Hunter , D.J. , Tosteson , T.D. and Ascher , M.S. 1996 . The lack of association of marijuana and other recreational drugs with progression to AIDS in the San Francisco Men's Health Study . Annals of Epidemiology , 6 ( 4 ) : 283 – 289 . doi: 10.1016/S1047-2797(96)00022-1
   PubMed Web of Science ®Google Scholar
• Hessol , N.A. , Kalinowski , A. , Benning , L. , Mullen , J. , Young , M. , Palella , F. and Cohen , M.H. 2007 . Mortality among participants in the multicenter AIDS cohort study and the women's interagency HIV study . Clinical Infectious Diseases , 44 ( 2 ) : 287 – 294 . doi: 10.1086/510488
   PubMed Web of Science ®Google Scholar
• Hinkin , C.H. , Barclay , T.R. , Castellon , S.A. , Levine , A.J. , Durvasula , R.S. , Marion , S.D. and Longshore , D. 2007 . Drug use and medication adherence among HIV-1 infected individuals . AIDS and Behavior , 11 ( 2 ) : 185 – 194 . doi: 10.1007/s10461-006-9152-0
   PubMed Web of Science ®Google Scholar
• Hogg , R.S. , Heath , K. , Bangsberg , D. , Yip , B. , Press , N. , O'Shaughnessy , M.V. and Montaner , J.S. 2002 . Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up . AIDS , 16 ( 7 ) : 1051 – 1058 . doi: 10.1097/00002030-200205030-00012
   PubMed Web of Science ®Google Scholar
• Johnson , M. , Sabin , C. and Girardi , E. 2010 . Definition and epidemiology of late presentation in Europe . Antiviral Therapy , 15 ( Suppl. 1 ) : 3 – 8 . doi: 10.3851/IMP1522
   PubMed Web of Science ®Google Scholar
• Kapadia , F. , Vlahov , D. , Donahoe , R.M. and Friedland , G. 2005 . The role of substance abuse in HIV disease progression: Reconciling differences from laboratory and epidemiologic investigations . Clinical Infectious Diseases , 41 ( 7 ) : 1027 – 1034 . doi: 10.1086/433175
   PubMed Web of Science ®Google Scholar
• Kipp , A.M. , Desruisseau , A.J. and Qian , H. 2011 . Non-injection drug use and HIV disease progression in the era of combination antiretroviral therapy . Journal of Substance Abuse Treatment , 40 ( 4 ) : 386 – 396 . doi: 10.1016/j.jsat.2011.01.001
   PubMed Web of Science ®Google Scholar
• Lemly , D.C. , Shepherd , B.E. , Hulgan , T. , Rebeiro , P. , Stinnette , S. , Blackwell , R.B. and Raffanti , S.P. 2009 . Race and sex differences in antiretroviral therapy use and mortality among HIV-infected persons in care . Journal of Infectious Diseases , 199 ( 7 ) : 991 – 998 . doi: 10.1086/597124
   PubMed Web of Science ®Google Scholar
• Lima , V.D. , Harrigan , R. , Bangsberg , D.R. , Hogg , R.S. , Gross , R. , Yip , B. and Montaner , J.S. 2009 . The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time . Journal of Acquired Immune Deficiency Syndromes , 50 ( 5 ) : 529 – 536 . doi: 10.1097/QAI.0b013e31819675e9
   PubMed Web of Science ®Google Scholar
• Lucas , G.M. , Cheever , L.W. , Chaisson , R.E. and Moore , R.D. 2001 . Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection . Journal of Acquired Immune Deficiency Syndromes , 27 ( 3 ) : 251 – 259 .
   PubMed Web of Science ®Google Scholar
• Lucas , G.M. , Gebo , K.A. , Chaisson , R.E. and Moore , R.D. 2002 . Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic . AIDS , 16 ( 5 ) : 767 – 774 . doi: 10.1097/00002030-200203290-00012
   PubMed Web of Science ®Google Scholar
• McGowan , C.C. , Weinstein , D.D. , Samenow , C.P. , Stinnette , S.E. , Barkanic , G. , Rebeiro , P.F. and Hulgan , T. 2011 . Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohorts . PLoS One , 6 ( 4 ) : e18462 doi: 10.1371/journal.pone.0018462
   PubMed Web of Science ®Google Scholar
• Mills , E.J. , Nachega , J.B. , Bangsberg , D.R. , Singh , S. , Rachlis , B. , Wu , P. and Cooper , C. 2006 . Adherence to HAART: A systematic review of developed and developing nation patient-reported barriers and facilitators . PLoS Medicine , 3 ( 11 ) : e438 doi: 10.1371/journal.pmed.0030438
   PubMed Web of Science ®Google Scholar
• Mocroft , A. , Ledergerber , B. , Katlama , C. , Kirk , O. , Reiss , P. , d’ Arminio Monforte , A. , EuroSIDA study group . 2003 . Decline in the AIDS and death rates in the EuroSIDA study: An observational study . Lancet 362 ( 9377 ), 22 – 29 . doi: 10.1016/S0140-6736(03)13802-0
   PubMed Web of Science ®Google Scholar
• Nair , M.P. , Chadha , K.C. and Hewitt , R.G. 2000 . Cocaine differentially modulates chemokine production by mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients . Clinical and Diagnostic Laboratory Immunology , 7 ( 1 ) : 96 – 100 .
   PubMedGoogle Scholar
• Panel on Antiretroviral Guidelines for Adults and Adolescents . 2011 . Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents . Department of Health and Human Services . 1 – 167 . Retrieved January 15, 2012, from http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf
   Google Scholar
• Purcell , D.W. , Moss , S. , Remien , R.H. , Woods , W.J. and Parsons , J.T. 2005 . Illicit substance use, sexual risk, and HIV-positive gay and bisexual men: Differences by serostatus of casual partners . AIDS , 19 ( Suppl. 1 ) : S37 – S47 . doi: 10.1097/01.aids.0000167350.00503.db
   PubMed Web of Science ®Google Scholar
• Qian , H.Z. , Stinnette , S.E. , Rebeiro , P.F. , Kipp , A.M. , Shephered , B.E. , Samenow , C.P. and Sterling , T.R. 2011 . The relationship between injection and noninjection drug use and HIV disease progression . Journal of Substance Abuse Treatment , 41 ( 1 ) : 14 – 20 . doi: 10.1016/j.jsat.2011.01.007
   PubMed Web of Science ®Google Scholar
• Simoni , J.M. , Kurth , A.E. , Pearson , C.R. , Pantalone , D.W. , Merrill , J.O. and Frick , P.A. 2006 . Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management . AIDS and Behavior , 10 : 227 – 245 . doi: 10.1007/s10461-006-9078-6
   PubMed Web of Science ®Google Scholar
• Sohler , N.L. , Wong , M.D. , Cunningham , W.E. , Cabral , H. , Drainoni , M.L. and Cunningham , C.O. 2007 . Type and pattern of illicit drug use and access to health care services for HIV-infected people . AIDS Patient Care and STDs , 21 ( Suppl. 1 ) : S68 – S76 .
   PubMed Web of Science ®Google Scholar
• Sullivan , P.S. , Nakashima , A.K. , Purcell , D.W. and Ward , J.W. 1998 . Geographic differences in noninjection and injection substance use among HIV-seropositive men who have sex with men: Western United States versus other regions. Supplement to HIV/AIDS Surveillance Study Group . Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology , 19 ( 3 ) : 266 – 273 . doi: 10.1097/00042560-199811010-00009
   PubMedGoogle Scholar
• Tashkin , D.P. 2005 . Evidence implicating cocaine as a possible risk factor for HIV infection . Journal of Immunology , 147 ( 1–2 ) : 26 – 27 .
   Google Scholar
• Toobert , D.J. , Hampson , S.E. and Glasgow , R.E. 2000 . The summary of diabetes self-care activities measure: Results from 7 studies and a revised scale . Diabetes Care , 23 ( 7 ) : 943 – 950 . doi: 10.2337/diacare.23.7.943
   PubMed Web of Science ®Google Scholar
• Tucker , J.S. , Burnam , M.A. , Sherbourne , C.D. , Kung , F.Y. and Gifford , A.L. 2003 . Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection . American Journal of Medicine , 114 ( 7 ) : 573 – 580 . doi: 10.1016/S0002-9343(03)00093-7
   PubMed Web of Science ®Google Scholar
• Turner , B.J. , Fleishman , J.A. , Wenger , N. , London , A.S. , Burnam , M.A. , Shapiro , M.F. and Bozzette , S.A. 2001 . Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons . Journal of General Internal Medicine , 16 ( 9 ) : 625 – 633 . doi: 10.1046/j.1525-1497.2001.016009625.x
   PubMed Web of Science ®Google Scholar
• Walensky , R.P. , Paltiel , A.D. , Losina , E. , Mercincavage , L.M. , Schackman , B.R. , Sax , P.E. and Freedberg , K.A. 2006 . The survival benefits of AIDS treatment in the United States . Journal of Infectious Diseases , 194 ( 1 ) : 11 – 19 . doi: 10.1086/505147
   PubMed Web of Science ®Google Scholar
• Weintrob , A.C. , Grandits , G.A. , Agan , B.K. , Ganesan , A. , Landrum , M.L. , Crum-Cianflone , N.F. , IDCRP HIV Working Group . 2009 . Virologic response differences between African Americans and European Americans initiating highly active antiretroviral therapy with equal access to care . Journal of Acquired Immune Deficiency Syndromes 52 ( 5 ), 574 – 580 . doi: 10.1097/QAI.0b013e3181b98537
   PubMed Web of Science ®Google Scholar
• Wilson , I.B. , Carter , A.I. and Berg , K.M. 2009 . Improving the self-report of HIV antiretroviral medication adherence: Is the glass half full or half empty? . Current HIV/AIDS Reports , 6 ( 4 ) : 177 – 186 . doi: 10.1007/s11904-009-0024-x
   PubMedGoogle Scholar
• Wood , E. , Montaner , J.S. , Yip , B. , Tyndall , M.W. , Schechter , M.T. , O'Shaughnessy , M.V. and Hogg , R.S. 2003 . Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users . Canadian Medical Association Journal , 169 ( 7 ) : 656 – 661 .
   PubMed Web of Science ®Google Scholar